
Manuel Portero Otin
Grau: Doctor/a
973 702 408
manuel.portero(ELIMINAR)@udl.cat
ResearcherID: http://www.researcherid.com/rid/B-7122-2009
Publicacions
-
Montserrat-Capdevila, J; Seminario, MA; Godoy, P; Marsal, JR; Ortega, M; Pujol, J; Castan, MT; Alseda, M; Betriu À; Lecube, A; Portero, M; Purroy, F; Valdivielso, JM; Barbe, F
Prevalence of chronic obstructive pulmonary disease (COPD) not diagnosed in a population with cardiovascular risk factors
MEDICINA CLINICA 151 383-389. .
-
Moreno-Navarrete, JM; Liñares-Pose L; Sabater, M; Rial-Pensado, E; Comas, F; Jove, M; Latorre, J; Ortega, F; Ricart, W; Portero-Otin, M; Lopez, M; Fernandez-Real, JM
Adipose TSHB in Humans and Serum TSH in Hypothyroid Rats Inform About Cellular Senescence
Cellular Physiology And Biochemistry 51 142-153. .
-
Servia, L; Serrano JCE; Pamplona, R; Badia, M; Montserrat, N; Portero-Otin, M; Trujillano, J
Location-dependent effects of trauma on oxidative stress in humans
PLOS ONE 13 -. .
-
Dominguez-Gonzalez, M; Puigpinos, M; Jove, M; Naudi, A; Portero-Otin, M; Pamplona, R; Ferrer, I
Regional vulnerability to lipoxidative damage and inflammation in normal human brain aging
Experimental Gerontology 111 218-228. .
-
Ranea-Robles, P; Launay, N; Ruiz, M; Calingasan, NY; Dumont, M; Naudi, A; Portero-Otin, M; Pamplona, R; Ferrer, I; Beal, MF; Fourcade, S; Pujol, A
Aberrant regulation of the GSK-3 beta/NRF2 axis unveils a novel therapy for adrenoleukodystrophy
Embo Molecular Medicine 10 -. .
-
Cambray, S; Portero-Otin, M; Jove, M; Torreguitart, N; Colàs-Campàs L; Sanz, A; Benabdelhak, I; Yemisci, M; Dalkara, T; Dönmez-Demir B; Egea, J; Purroy, F
Metabolomic Estimation of the Diagnosis and Onset Time of Permanent and Transient Cerebral Ischemia
MOLECULAR NEUROBIOLOGY 55 6193-6200. .
-
Cabre, R; Naudi, A; Dominguez-Gonzalez, M; Jove, M; Ayala, V; Mota-Martorell, N; Pradas, I; Nogueras, L; Rue, M; Portero-Otin, M; Ferrer, I; Pamplona, R
Lipid Profile in Human Frontal Cortex Is Sustained Throughout Healthy Adult Life Span to Decay at Advanced Ages
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES 73 703-710. .
-
Lozano-Bartolome, J; Llaurado, G; Otin MP; Altuna-Coy, A; Rojo-Martinez, G; Vendrell, J; Jorba, R; Rodriguez-Gallego, E; Chacon, MR
Altered Expression of miR-181a-5p and miR-23a-3p Is Associated With Obesity and TNF alpha-Induced Insulin Resistance
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 103 1447-1458. .
-
Zhu, C; Farre, G; Zanga, D; Lloveras, J; Michelena, A; Ferrio, JP; Voltas, J; Slafer, G; Savin, R; Albajes, R; Eizaguirre, M; Lopez, C; Cantero-Martinez, C; Diaz-Gomez, J; Nogareda, C; Moreno, JA; Angulo, E; Estany, J; Pena, RN; Tor, M; Portero-Otin, M; Eritja, N; Arjo, G; Serrano, JCE; Matias-Guiu, X; Twyman, RM; Sandmann, G; Capell, T; Christou, P
High-carotenoid maize: development of plant biotechnology prototypes for human and animal health and nutrition
PHYTOCHEMISTRY REVIEWS 17 195-209. .
-
Chacon, MR; Lozano-Bartolome, J; Portero-Otin, M; Rodriguez, MM; Xifra, G; Puig, J; Blasco, G; Ricart, W; Chaves, FJ; Fernandez-Real, JM
The gut mycobiome composition is linked to carotid atherosclerosis
BENEFICIAL MICROBES 9 185-198. .
-
Torres, P; Ramirez-Nunez, O; Romero-Guevara, R; Bares, G; Granado-Serrano, AB; Ayala, V; Boada, J; Fontdevila, L; Povedano, M; Sanchis, D; Pamplona, R; Ferrer, I; Portero-Otin, M
Cryptic exon splicing function of TARDBP interacts with autophagy in nervous tissue
Autophagy 14 1398-1403. .
-
Berdun, R.; Font, MJ; Font-i-Furnols, M.; Moreno, J.; Rodriguez-Palmero, M.; Valent, D.; Tibau, J.; Portero-Otin, M.
EFFECTS OF DIET SUPPLEMENTATION ON CEREBRAL POLYUNSATURATED FATTY ACID PROFILE AND PROTEIN OXIDATIVE MODIFICATION IN A PORCINE MODEL OF OBESITY
ANNALS OF NUTRITION AND METABOLISM 73 66-66. .
Projectes
- SEED-ALS: Synergizing Efforts to Develop and Accelerate Breakthroughs in ALS Research
- Natural microbicides from rice against current and emerging infectious diseases
- Humanised mouse models to study ATG4B cryptic exon involvement in ALS pathogenesis and its potential as disease biomarker (Hum4ALS)
- Targeting cryptic exons as biomarkers and ALS therapy
- Desregulacion de TDP-43,eje clave en la ELA: Caracterización de firmas lipidómicas, transcriptómicas y autofágicas en muestras específicas de pacientes para biomarcadores y reposicionamiento
- Comprehensive Roadmap and Preclinical Evaluation of Antisense Oligonucleotides (ASOs) Regulatory Development and Toxicological Assessment for ALS Treatment
- The role of defects in mitochondria-associated ER membranes (MAM) to Amyotrophic Lateral Sclerosis
- Perspectivas clínicas de la biología de sistemas aplicada al análisis de placas carotídeas humanas: ILER-CAROTID
- Metabolismo lipidico intracelular, procesamiento de ARNm y estrés celular en la encrucijada de la fisiopatología de la esclerosis lateral amiotrófica
- Identification of compounds for inhibition of ACE2 membrane expression
- Reposicionamiento terapéutico dirigido a inhibición de expresión de ACE2 y de proteolisis de trímero S viral
- Determinació de components bioactius derivats de la microbiota mitjançant micromostreig